TC
EGRX

TFS Capital’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

TFS Capital’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-34,860
Closed -$2.82M – 1065
2015
Q2 		$2.82M Buy
34,860
+12,108
+53% +$979K 0.28% 86
2015
Q1 		$953K Buy
+22,752
New +$953K 0.09% 363